Browse All

Current Filters

CLEAR FILTER x

TITLE

Author:

Assessment Of Acute Ischemic Stroke Disparities By Primary Language In A High Patient Volume Comprehensive Stroke Center Serving A Diverse Metropolitan City:

Mechanical Thrombectomy Versus Combined Thrombectomy and Intravenous Thrombolysis in Tandem Lesions

Author:Rodriguez-Calienes, Aaron   Galecio-Castillo, Milagros   Farooqui, Mudassir   Sheth, Sunil   Yoo, Albert   Divani, Afshin   Petersen, Nils   Abraham, Michael   Fifi, Johanna   Guerrero, Waldo   Malik, Amer   Siegler, James   Nguyen, Thanh   Linares, Guillermo   Janjua, Nazli   Quispe Orozco, Darko   Zaidi, Syed   Kobsa, Jessica   Prasad, Ayush   Ikram, Asad   Zevallos, Cynthia   Requena, Manuel   Olive Gadea, Marta   Qureshi, Abid   Barkley, Tiffany   Matsuokas, Stavros   Abdalkader, Mohamad   Salazar Marioni, Sergio   Soomro, Jazba   Vivanco-Suarez, Juan   Edgell, Randall   Mokin, Maxim   Yavagal, Dileep   Jumaa, Mouhammad   Hassan, Ameer   Ortega Gutierrez, Santiago   

Session Name:S24: Cerebrovascular Disease and Interventional Neurology: Endovascular Thrombectomy and Large Vessel Occlusions  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:S24.003  

Author Institution:University of Iowa Hospitals and Clinics, Iowa City, IA  University of Texas At Houston, Houston, TX  Texas Stroke Institute, Houston, UT  University of New Mexico, Albuquerque, NM  Yale University, New Haven, CT  The University of Kansas Health System, Kansas City, KS  Mount Sinai Hospital, New York, NY  University of South Florida College of Medicine , Tampa, FL  University of Miami Miller School of Medicine, Miami, FL  Cooper University Hospital, Camden, NJ  Boston Medical Center, Boston, MA  Saint Louis University, Philadelphia, PA  Pomona Valley Hospital Medical Center, Montclair, CA  TTUHSC-SOM, Lubbock  Neurology Dept., Lubbock, TX  ProMedica Stroke Network, Toledo, OH  Yale School of Medicine & Yale - New Haven Hospital, Flatwoods, KY  Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA  Hospital Vall d Hebron, Barcelona, Spain  Vall D'Hebron Hospital, Barcelona, Spain  University of Kansas Medical Center, Kansas City, KS  University of Kansas, Kansas City, KS  Icahn School of Medicine at Mount Sinai, New Have, CT  UT Health McGovern Medical School, Boston, MA  UT Health McGovern Medical School, Houston, TX  Texas Stroke Institute, Plano, TX  Saint Louis University, Saint Louis, MO  University of South Florida, Tampa, FL  Valley Baptist Medical Center, Harlingen, TX  

Effect of Antiplatelet Therapy in Acute Ischemic Stroke with Tandem Lesions

Author:Farooqui, Mudassir   Galecio-Castillo, Milagros   Divani, Afshin   Malik, Amer   Petersen, Nils   Abraham, Michael   Fifi, Johanna   Guerrero, Waldo   Siegler, James   Nguyen, Thanh   Sheth, Sunil   Yoo, Albert   Linares, Guillermo   Janjua, Nazli   Zaidi, Syed   Kobsa, Jessica   Prasad, Ayush   Ikram, Asad   Zevallos, Cynthia   Quispe Orozco, Darko   Requena, Manual   Olive Gadea, Marta   Qureshi, Abid   Barkley, Tiffany   Dajles, Andres   Matsoukas, Stavros   Rana, Ameena   Abdalkader, Mohamad   Marioni, Sergio   Soomro, Jazba   Vivanco-Suarez, Juan   Edgell, Randall   Mokin, Maxim   Yavagal, Dileep   Jumaa, Mouhammad   Hassan, Ameer   Ortega-Gutierrez, Santiago   

Session Name:P7: Cerebrovascular Disease and Interventional Neurology: Thrombolytic Therapy and Acute Stroke Treatments  

Topic:Cerebrovascular Disease and Interventional Neurology  

Program Number:P7.001  

Author Institution:University of Iowa, Iowa City, IA  University of Iowa Hospitals and Clinics, Iowa City, IA  University of New Mexico, Albuquerque, NM  University of Miami Miller School of Medicine, Miami, FL  Yale University, New Haven, CT  The University of Kansas Health System, Kansas City, KS  Mount Sinai Hospital, New York, NY  University of South Florida College of Medicine , Tampa, FL  Cooper University Hospital, Camden, NJ  Boston Medical Center, Boston, MA  University of Texas At Houston, Houston, TX  Texas Stroke Institute, Dallas, TX  St Louis University , Philadelphia, PA  Pomona valley, Montclair, CA  ProMedica Stroke Network, Toledo, OH  Yale School of Medicine & Yale - New Haven Hospital, Flatwoods, KY  Harvard Medical School/ Beth Israel Deaconess Medical Center, Boston, MA  University of Iowa , Iowa City, IA  TTUHSC-SOM, Lubbock  Neurology Dept., Lubbock, TX  Vall de Hebron, barcelona, Spain  Kansas Medical Center, Kansas City, KS  University of Kansas, Kansas City, KS  Mt Sinai, Newyork City, NY  Cooper , Old Bridge, NJ  University of Texas, Houston, TX  St Louis University , Saint Louis, MO  University of South Florida, Tampa, FL  Valley Baptist Medical Center, Harlingen, TX  

Safety, Tolerability, And Efficacy Of NE3107 From A Phase 2, Double-Blind, Placebo-Controlled Study In Levodopa/Carbidopa-Treated Patients With Parkinson's Disease

Pregnancy Outcomes in Patients With MS Following Exposure to Ofatumumab: Updated Results From the Novartis Safety Database

Author:Bove, Riley   Pia Amato, Maria   Dobson, Ruth   M. Krysko, Kristen   Stoll, Sharon   Vukusic, Sandra   Yamout, Bassem   Zielman, Ronald   Krishna Gummuluri, Swetha   Jehl, Valentine   Schulze Topphoff, Ulf   Sullivan, Roseanne   Fantaccini, Simone   Hellwig, Kerstin   

Session Name:P9: MS Special Populations  

Topic:MS and Inflammatory Disease  

Program Number:P9.014  

Author Institution:UCSF Weill Institute for Neuroscience, University of California San Francisco, San Francisco, California, USA, Berkeley, CA  Department NEUROFARBA, University of Florence, Florence, Italy  IRCCS Fondazione Don Carlo Gnocchi, Florence, Italy, Florence, Italy  Preventive Neurology Unit, Wolfson Institute of Population Health, Queen Mary University of London, London, United Kingdom  Department of Neurology, Royal London Hospital, Barts Health NHS Trust, London, United Kingdom, London, United Kingdom  Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, Ontario, Canada  Li Ka Shing Knowledge Institute, St. Michael’s Hospital, Toronto, Ontario, Canada, Toronto, ON, Canada  Department of Neurology, Yale University, New Haven, Connecticut, USA, New Haven, CT  Service de neurologie, sclérose en plaques, pathologies de la myéline et neuro-inflammation, Hôpital neurologique Pierre Wertheimer, Hospices Civils de Lyon, Lyon, France  Centre des Neurosciences de Lyon, INSERM 1028 et CNRS UMR5292, Observatoire Français de la Sclérose en Plaques, Lyon, France  Université Claude Bernard Lyon 1, Villeurbanne, France, BRON Cedex, France  American University of Beirut Medical Center, Beirut, Lebanon  Harley Street Medical Centre, Abu Dhabi, UAE, Beirut, Lebanon  Novartis Pharma B.V., Amsterdam, The Netherlands, Haaksbergweg, Netherlands  Novartis Healthcare Pvt Ltd, Hyderabad, India, Hyderabad, India  Novartis Pharma A.G. Basel, Switzerland, Basel, Switzerland  Novartis Pharma GmbH, Germany, Nuernberg, Germany  Novartis Pharmaceuticals Corporation, East Hanover, New Jersey, USA, East Hanover, NJ  Novartis Pharma A.G. Basel, Switzerland, Binningen, Switzerland  St. Josef-Hospital/Ruhr-University Bochum, Bochum, Germany, Bochum, Germany